About Contact Us Careers

Heart Attack Diagnostics Market Size and Forecast, by Type (Non-Invasive, Minimally Invasive); Test (Electrocardiography, Blood Tests, Computerized Cardiac Tomography, Echocardiography, Coronary Angiography); End-user (Hospitals & Clinics, Diagnostic Center, Ambulatory & Surgical Centers) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 4446
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Heart Attack Diagnostics Market Outlook:

Heart Attack Diagnostics Market size was over USD 13.14 billion in 2025 and is projected to reach USD 27.08 billion by 2035, growing at around 7.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of heart attack diagnostics is evaluated at USD 14.03 billion.

Heart Attack Diagnostics Market size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The growth of the market can primarily be ascribed to the rising number of people suffering from heart attacks globally, owing to unhealthy lifestyles, consumption of fatty food items, and illnesses. According to the Centers for Disease Control and Prevention in the United States, about 805,000 people have a heart attack each year. There are 605,000 first-time heart attacks among these. In 200,000 cases, people who have already suffered a heart attack are affected. 

Global heart attack diagnostics market trends such as, the rising disposable income of the population along with rising healthcare expenditure and rapid awareness about health and fitness is expected to boost up the global market in the forecast period. Centers for Medicare & Medicaid Services stated that U.S. health care spending grew 9.7 percent in 2020, reaching USD 4.1 trillion or USD 12,530 per person. Moreover, pre heart attack symptoms should be known by everyone to avoid these unpleasant instances since even a mild heart attack can cause severe medical conditions. Mild heart attack symptoms include tightness & squeezing in the chest, fatigue, heartburn, nausea, dizziness, and others.

Key Heart Attack Diagnostics Market Insights Summary:

  • Regional Highlights:

    • The North America heart attack diagnostics market will dominate over 39.3% share by 2035, fueled by rising cardiac disease incidence, high healthcare spending, and advanced infrastructure.

  • Segment Insights:

    • The hospitals & clinics (end-user) segment in the heart attack diagnostics market is forecasted to experience noteworthy growth over 2026-2035, driven by the high number of surgical procedures and patient admissions in hospitals.
    • The electrocardiography (test) segment in the heart attack diagnostics market is expected to achieve noteworthy growth during 2026-2035, driven by ECG being the first mandatory test for diagnosing heart attacks and advancements in ECG devices.

  • Key Growth Trends:

    • Rise in Geriatric Population Worldwide
    • Higher Level of Cholesterol Among People

  • Major Challenges:

    • Rise in Geriatric Population Worldwide
    • Higher Level of Cholesterol Among People

  • Key Players: Abbott Laboratories, ACS Diagnostics, Company, Asahi Kasei Corporation, AstraZeneca PLC, Beckman Coulter, Inc., Hill-Rom Services, Inc, Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Schiller Americas, inc.

Global Heart Attack Diagnostics Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 13.14 billion
    • 2026 Market Size: USD 14.03 billion
    • Projected Market Size: USD 27.08 billion by 2035
    • Growth Forecasts: 7.5% CAGR (2026-2035)

  • Key Regional Dynamics:

    • Largest Region: North America (39.3% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, Germany, China, Japan, India
    • Emerging Countries: China, India, Japan, South Korea, Thailand

    • Last updated on : 9 September, 2025

Growth Drivers

  • Rise in Geriatric Population Worldwide - Globally, there were 747,238,580 people over 60 years old at the end of 2021 according to a recent World Bank report. Future projections indicate an increase in the number. Cardiovascular disease is more prevalent among the elderly and the aging population. Adults with cardiovascular disease are at an increased risk of CVD owing to their age, which is increased by contributing factors such as fragility, overweight, and diabetes. Moreover, aging populations are more likely to suffer from heart attacks because they are more vulnerable to heart diseases.
  • Higher Level of Cholesterol Among People- As per the data by the Centers for Disease Control and Prevention, the total cholesterol level of nearly 94 million U.S. adults aged 20 or older exceeds 200 mg/dL. A total of 28 million Americans has a cholesterol level above 240 milligrams per deciliter.
  • Increasing Consumption of Alcohol - The consumption of alcohol is directly related to a higher risk of stroke and heart failure. According to a survey of adults ages 18 and older, 84% reported drinking alcohol at some point in their lives across the globe.
  • High Rate of Tobacco Smoking- For instance, the number of adults smoking cigarettes in the United States is estimated at 30.8 million. There are more than 16 million Americans who suffer from smoking-related diseases.
  • Prevalence of Unhealthy Lifestyles Among People - It was observed that, there are approximately 677,000 deaths each year in the United States as a result of unhealthy lifestyles, such as cardiovascular disease, cancer, and diabetes, which are linked to nutrition and obesity.

Challenges

  • Higher Price Associated with Diagnostic Products – Even if heart attack cases are increasing at an alarming rate, heart attack diagnostic procedure cost a fortune owing to high price of diagnostic products. As a result, the population with middle income is expected to slower the adoption rate of heart diagnostic in the forecast period.
  • Shortage of Skilled Medical Professionals
  • Inadequate Medicare Reimbursement Policies

Heart Attack Diagnostics Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Period

2026-2035

CAGR

7.5%

Base Year Market Size (2025)

USD 13.14 billion

Forecast Year Market Size (2035)

USD 27.08 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Heart Attack Diagnostics Market Segmentation:

End-user Segment Analysis

The global heart attack diagnostics market is segmented and analyzed for demand and supply by end-user into hospitals & clinics, diagnostic center, and ambulatory & surgical centers. Out of which, the hospitals & clinics segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the high number of surgical procedures performed in hospital settings, and the high number of hospitals present in the world. It was observed that more than 850,000 cardiac surgeries are performed each year in the United States. Moreover, the rising number of heart patient admissions in hospitals along with the increasing pharma sector is anticipated to augment segment growth over the forecast period.

Test Segment Analysis

Furthermore, the global heart attack diagnostics market is segmented and analyzed for demand and supply by test into electrocardiography, blood tests, computerized cardiac tomography, echocardiography, coronary angiography, and others. Out of which, the electrocardiography (ECG) segment is projected to witness noteworthy growth over the forecast period. The growth of the segment is boosted by the fact that it is the first and mandatory test that is performed to diagnose heart attack when the patients get admitted to the hospitals. Based on the data provided by the World Health Organization (WHO), it was stated that in 2019, around 17.9 million people across the globe lost their lives owing to cardiovascular diseases (CVDs), out of which, 85% were caused by a heart attack. Hence, such a higher prevalence of heart attacks is estimated to hike the number of echocardiography test performed in the hospitals over the forecast period. Furthermore, there has been advancement in the ECG devices for diagnosing heart attack, and it is expected to drive the growth of the segment in the heart attack diagnostics market.

Our in-depth analysis of the global heart attack diagnostics market includes the following segments:

               By Type
  • Non-Invasive
  • Minimally Invasive

              By Test
  • Electrocardiography
  • Blood Tests
  • Computerized Cardiac Tomography
  • Echocardiography
  • Coronary Angiography
  • Others

               By End User
  • Hospitals & Clinics
  • Diagnostic Center
  • Ambulatory & Surgical Centers
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Heart Attack Diagnostics Market Regional Analysis:

North America region is anticipated to hold over 39.3% market share by 2035, fueled by rising cardiac disease incidence, high healthcare spending, and advanced infrastructure. According to the Centers for Medicare & Medicaid Services, United States healthcare expenditures reached USD 4.1 trillion in 2020, representing 19.7% of GDP. Furthermore, healthcare spending in the United States is expected to reach USD 6.2 trillion by 2028, an annual growth rate of 5.4%. Moreover, along with the technologically advanced healthcare infrastructure, the surging awareness among people for the right amount of dose of hypertension drugs, followed by the high number of people suffering from hypertension and the presence of major market players in the region are expected to drive the global heart attack diagnostics market in North America during the forecast period. Moreover, people are suffering from these diseases and disorders at a higher rate in the region since Americans consume more calories than they burn. For instance, nearly 60% of the Americans suffer from obesity in the United States which is one of the significant reasons to escalate the number of heart attack. It is estimated that every year, more than 800,000 people encounter heart attack in the USA. All these factors are, therefore, anticipated to expand the heart attack diagnostics market size in the region throughout the forecast period. 

Heart Attack Diagnostics Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Heart Attack Diagnostics Market Players:

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ACS Diagnostics, Company
    • Asahi Kasei Corporation
    • AstraZeneca PLC
    • Beckman Coulter, Inc.
    • Hill-Rom Services, Inc
    • Koninklijke Philips N.V.
    • General Electric Company
    • Toshiba Corporation
    • Schiller Americas, inc.  

Recent Developments

  • General Electric Company, a global leader in medical technology, diagnostics and digital solutions, has launched the first AI-enabled Cath lab made in India - Optima IGS 320, enabling cardiac care in India. The lab is located at the new factory of Wipro GE Healthcare in Bengaluru. The managing director of the company further suggested that AI has the requisite potential to enhance the care pathway.  

  • Abbott Laboratories to received CE marking for its first troponin test that may be able to allow prediction of heart attacks months in advance in apparently healthy adults. It can help the physicians to determine necessary medical steps to prevent heart diseases.

  • Report ID: 4446
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of heart attack diagnostics is evaluated at USD 14.03 billion.

The global heart attack diagnostics market size was worth over USD 13.14 billion in 2025 and is poised to grow at a CAGR of around 7.5%, reaching USD 27.08 billion revenue by 2035.

The North America heart attack diagnostics market will dominate over 39.3% share by 2035, fueled by rising cardiac disease incidence, high healthcare spending, and advanced infrastructure.

Key players in the market include Abbott Laboratories, ACS Diagnostics, Company, Asahi Kasei Corporation, AstraZeneca PLC, Beckman Coulter, Inc., Hill-Rom Services, Inc, Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Schiller Americas, inc.

Heart Attack Diagnostics Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos